|
ZNF518B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.97479835104286E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.1191000000349E-07 |
| Normal-vs-Stage2 |
1.96000000007857E-07 |
| Normal-vs-Stage3 |
5.41344746807226E-13 |
| Normal-vs-Stage4 |
5.74473801862041E-12 |
| Stage1-vs-Stage2 |
9.183900E-02 |
| Stage1-vs-Stage3 |
1.9990099999978E-05 |
| Stage1-vs-Stage4 |
4.40459999995202E-06 |
| Stage2-vs-Stage3 |
1.396230E-01 |
| Stage2-vs-Stage4 |
1.637740E-02 |
| Stage3-vs-Stage4 |
2.228200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.38539957283967E-10 |
| Normal-vs-AfricanAmerican |
2.997900E-04 |
| Normal-vs-Asian |
2.51209999468927E-08 |
| Caucasian-vs-AfricanAmerican |
8.802600E-01 |
| Caucasian-vs-Asian |
4.846000E-01 |
| AfricanAmerican-vs-Asian |
8.355000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.05769997999539E-09 |
| Normal-vs-Female |
1.88279947188619E-10 |
| Male-vs-Female |
7.860000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.52908999999646E-05 |
| Normal-vs-Age(41-60Yrs) |
1.40889966360191E-10 |
| Normal-vs-Age(61-80Yrs) |
2.82474044155379E-12 |
| Normal-vs-Age(81-100Yrs) |
2.041000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.163200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.23419999997765E-06 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.469800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.686300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.181200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.904000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.80670000071714E-08 |
| Classical-VS-Follicular |
4.405800E-01 |
| Classical-VS-Other |
7.388200E-01 |
| Classical-VS-Normal |
2.36620001370369E-09 |
| Tall-VS-Follicular |
1.71940000015525E-07 |
| Tall-VS-Other |
1.091650E-01 |
| Tall-VS-Normal |
1.63125069008174E-12 |
| Follicular-VS-Other |
5.823600E-01 |
| Follicular-VS-Normal |
1.96450999999653E-05 |
| Other-VS-Normal |
1.163610E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02119999626049E-08 |
| Normal-vs-N1 |
9.987299876002E-11 |
| N0-vs-N1 |
1.043860E-02 |
|
|
